• Your Liver
  • Liver Health and Wellness
    • Healthy Recipes
  • Liver Disease Information
• Patients & Families
  • Caregiver's FAQ
  • Become an Organ Donor
    • More Information
  • CaringBridge
• Education Resources
  • Helpful Resources
    • Informacion espanola
  • Voices of Liver Disease
  • Liver Update Webcasts
  • Related Links
  • Liver Lowdown
    • Liver Lowdown June 2013
    • Liver Lowdown July 2013
      • World Hep Day 2013
      • HE Q&A
      • Patient Story-Lynette
      • In the Field
      • Call to Action
      • 5 Things About Hep
      • Healthy Summer Tips
    • Liver Lowdown Aug 2013
      • Disney Marathon
      • In The Field
      • Healthy Foods
      • Diet Recommendations
      • Pediatric Liver Disease Q&A
      • Life After Diagnosis
      • Support for Chronic Illness
      • Corporate Partnerships
      • Interview with Kristen Hanks
    • Liver Lowdown Sept 2013
      • Recovery Month
      • Path to Wellness
      • 5 Facts About Recovery
      • Patient Story
      • In the Field
      • T or F Liver Info
      • HE 123
      • Drive Away Liver Disease
• Support Services
• Healthcare Professionals
  • Research Awards
• Glossary

Program Archive: Professional Education

2010 Academic Debates

Topic #1

Il 28 will continue to have a role after DAAs B 2010 Academic debates Debate 1

Il 28B Will diminish after DAAs 449.2KB 2010 Academic Debates Debate 1 con

Topic #2

Cessation of Antiviral 1.9MB >2010 Academic Debates Debate 2 Pro UIC

Continue therapy indefinitely unless loss of sAg occurs 629.2KB 2010 Academic Debates Debate 2 con Loyola

Topic #3

TZD SHOULD BE USED TO Treat Advanced NASH 939.5KB 2010 Academic debates Debate 3 pro Northwestern

2009 Academic Debates

Topic #1

Autoimmune Hepatitis: In cases that achieved remission, continue immunosuppression maintenance vs. stop and watch. No 7.5MB >Department of Gastroenterology of Chicago Medical Center>R Mufti and Archita P Desai>2009 Academic Debates

Maintenance Immunosuppression in Patients with Autoimmune Hepatitis (AIH). Yes 958.0KB Lau, MD Behara, MD

Topic #2

ERCP Directly in Cases of Suspected Bile Duct Stones. No 163.7KB Miller, MD Chopra, MD Brown, MD of Illinois at Chicago

Topic #3

Early Use of Renal Sparing Protocols. PRO 118.7KB Lam, DO Birris, MD

Calcineurin Inhibitor Nephrotoxicity: Renal Sparing Protocol by Evidence of Renal Dysfunction. CON 433.8KB University Nealis and Neehar Parikh Josh Levitsky

2006 Academic Debates

Topic #1

Illinois Chapter - HCV: Mild Disease on Biopsy for Genotype 1, Should We Treat? - No 92.5KB University of Illinois - Chicago Eric Kallwitz, MD & Samuel Tesfay, MD Mentor: Jamie Berkes, MD 2006 Academic Debates

Illinois Chapter - HCV: Mild Disease on Biopsy for Genotype 1, Should We Treat? - Yes 103.0KB *WINNER* University of Chicago Hospitals Nidhi Singh, MD & Rohit Satoskar, MD Mentor: Nancy Reau, MD 2006 Academic Debates

Topic #2

Illinois Chapter - NASH: Using Medication To Treat Fatty Liver Disease: Are We There Yet? - No 75.6KB Loyola University Medical Center Ashish Arora, MD & William Levis, MD Mentor: Sonu Dhillon, MD 2006 Academic Debates

Illinois Chapter - NASH: Using Medication To Treat Fatty Liver Disease: Are We There Yet? - Yes 1.1MB Cook County Hospital Steve Keilin, MD & Cory Halliburton, MD Mentor: Bashar Attar, MD 2006 Academic Debates

Topic #3

Illinois Chapter - Should We Use Marginal Donors for Otherwise Good Risk Patients w/ HCC, Beyond Milan Criteria? - No 184.3KB *WINNER* Northwestern Memorial Hospital Paul Alvord, MD Mentor: Michael Abecassis, MD 2006 Academic Debates

Illinois Chapter - Should We Use Marginal Donors for Otherwise Good Risk Patients w/ HCC, Beyond Milan Criteria? - Yes 472.7KB Rush University Medical Center David Lee, MD Mentor: Forrest Dodson, MD 2006 Academic Debates

2005 Academic Debates

Topic #2

Illinois Chapter - Split Livers by Current UNOS Policy: Should We or Shouldn't We? - Con 1.1MB *TIE* University of Chicago Hospitals John Milner, MD Mentor: J. Michael Millis, MD 2005 Academic Debates

Illinois Chapter - Split Livers by Current UNOS Policy: Should We or Shouldn't We? - Pro 678.1KB *TIE* University of Illinois - Chicago Marion Porubsky, MD Mentor: Jose Oberholzer, MD 2005 Academic Debates

Topic # 2

Illinois Chapter - Treatment of Non-Responders w/ Cirrhosis - Concensus Interferon 229.0KB *WINNER* Rush University Medical Center Kevin Schaefer, MD & Sushama Gundlapalli, MD Mentor: S. Martin Cohen, MD 2005 Academic Debates

Illinois Chapter - Treatment of Non-Responders w/ Cirrhosis - Maintenance Therapy w/ Pegylated Interferon 2.8MB Loyola University Medical Center Peter Seraphin, MD & William Levis, MD Mentor: Nikunj Shah, MD 2005 Academic Debates

Illinois Chapter - Treatment of Non-Responders w/ Cirrhosis - Wait for Transplantation 500.3KB Northwestern Memorial Hospital Ramsey Umar, MD & Aaron Benson, MD Mentor: Richard Green, MD 2005 Academic Debates

Page updated: July 3rd, 2012

© Copyright 2013 American Liver Foundation. All Rights Reserved. The American Liver Foundation is a member of the World Hepatitis Alliance.